<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01330459</url>
  </required_header>
  <id_info>
    <org_study_id>OHSU FAMPLAN 6734</org_study_id>
    <nct_id>NCT01330459</nct_id>
  </id_info>
  <brief_title>Hydrocodone For Pain Control in First Trimester Surgical Abortion</brief_title>
  <official_title>An Evaluation of Hydrocodone/Acetaminophen for Pain Control in First Trimester Surgical Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elizabeth Micks</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Planned Parenthood Federation of America</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether preoperatively administered
      hydrocodone/acetaminophen (HC/APAP) reduces pain during a first trimester surgical abortion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators plan to conduct a double-blinded randomized placebo-controlled trial of 120
      women undergoing elective first trimester surgical abortion. These women will be premedicated
      with either two tabs of 5/350 hydrocodone/acetaminophen or 2 tabs of a placebo. All subjects
      will receive ibuprofen and lorazepam preoperatively and a PCB. This study will examine the
      incremental benefit of HC/APAP over this standard medication regimen. Randomization will be
      stratified into two groups. Subjects less than 8 weeks gestation will comprise the early
      gestational age group. Subjects between 8 weeks 0 days and 10 weeks 6 days will comprise the
      late gestational age group. The investigators will be assessing patient perception of pain,
      nausea, satisfaction, and anxiety at multiple points during the clinic visit using 100-mm
      visual analogue scales (VAS).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Perception of Pain</measure>
    <time_frame>At time of uterine aspiration (baseline)</time_frame>
    <description>To determine whether HC/APAP, given in addition to a standard regimen of ibuprofen, lorazepam, and PCB, affects patient pain perception at the time of uterine aspiration, as measured by distance (mm) from the left of the 100 mm visual analog scale (VAS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anticipated and reported pain at various time points</measure>
    <time_frame>One Year</time_frame>
    <description>Distance (mm) from the left of the 100 mm VAS scale (VAS anchors: 0 = none, 100 mm = worst imaginable) recorded:
prior to premedication
after receiving premedication, just prior to procedure
after speculum insertion
with placement of the PCB
with cervical dilation
30 minutes postoperatively
intrapersonal pain changes (calculated in analysis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Anxiety</measure>
    <time_frame>One Year</time_frame>
    <description>Distance (mm) from the left of the 100 mm VAS scale (VAS anchors: 0 = none, 100 mm = worst imaginable) recorded prior to premedication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with pain control and overall abortion experience</measure>
    <time_frame>One Year</time_frame>
    <description>Distance (mm) from the left of the 100 mm VAS (VAS anchors: 0 = unsatisfied, 100 mm = very satisfied) recorded 30 minutes after completion of the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>One Year</time_frame>
    <description>To assess whether HC/APAP is associated with the following side effects: nausea, pruritis and sleepiness using VAS Scales (VAS anchors: 0 = none, 100 mm = worst imaginable) recorded:
prior to premedication
30 minutes postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>One Year</time_frame>
    <description>To determine whether the effect of HC/APAP is associated with the following adverse events: allergic reaction, postabortal syndrome, need for uterine reaspiration, excessive blood loss, excessive sedation; recorded:
Preoperatively
intraoperatively
30 minutes postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for additional intraoperative and/or postoperative pain medication</measure>
    <time_frame>One Year</time_frame>
    <description>To assess need for additional intraoperative and/or postoperative pain medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants belief whether they received HC/APAP or placebo</measure>
    <time_frame>One Year</time_frame>
    <description>Participants belief whether they received HC/APAP or placebo recorded 30 minutes postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Hydrocodone/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will receive hydrocodone/acetaminophen 45-90 minutes prior to abortion procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject will receive placebo 45-90 minutes prior to abortion procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocodone/acetaminophen</intervention_name>
    <description>Administration of 2 tablets 5/325mg hydrocodone/acetaminophen 45-90 minutes prior to procedure.</description>
    <arm_group_label>Hydrocodone/acetaminophen</arm_group_label>
    <other_name>Vicodin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administration of 2 tablets methylcellulose (placebo) 45-90 minutes prior to procedure.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 years or older

          -  Voluntarily requesting surgical pregnancy termination

          -  Pregnancy with intrauterine gestational sac up to 10 weeks 6 days gestation, dated by
             ultrasound

          -  Eligible for suction curettage

          -  English or Spanish speaking

          -  Good general health

          -  Able and willing to give informed consent and agree to terms of the study

        Exclusion Criteria:

          -  Gestational ages 11 weeks or more

          -  Incomplete abortion

          -  Premedication with misoprostol

          -  Use of any opioid medication within the past 7 days

          -  Use of heroin within the past 7 days

          -  Requested opioids or IV sedation prior to start of the procedure

          -  Patients who refuse ibuprofen or lorazepam

          -  Contraindications or allergies to HC/APAP, lidocaine, ibuprofen, or lorazepam

          -  Significant medical problem necessitating inpatient procedure

          -  Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease

          -  Known hepatic disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Micks, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Planned Parenthood CW</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Allen RH, Kumar D, Fitzmaurice G, Lifford KL, Goldberg AB. Pain management of first-trimester surgical abortion: effects of selection of local anesthesia with and without lorazepam or intravenous sedation. Contraception. 2006 Nov;74(5):407-13. Epub 2006 Aug 2.</citation>
    <PMID>17046383</PMID>
  </reference>
  <reference>
    <citation>Bélanger E, Melzack R, Lauzon P. Pain of first-trimester abortion: a study of psychosocial and medical predictors. Pain. 1989 Mar;36(3):339-50.</citation>
    <PMID>2710563</PMID>
  </reference>
  <reference>
    <citation>Bone ME, Dowson S, Smith G. A comparison of nalbuphine with fentanyl for postoperative pain relief following termination of pregnancy under day care anaesthesia. Anaesthesia. 1988 Mar;43(3):194-7.</citation>
    <PMID>3364636</PMID>
  </reference>
  <reference>
    <citation>Dahl V, Fjellanger F, Raeder JC. No effect of preoperative paracetamol and codeine suppositories for pain after termination of pregnancies in general anaesthesia. Eur J Pain. 2000;4(2):211-5.</citation>
    <PMID>10957701</PMID>
  </reference>
  <reference>
    <citation>Edelman A, Nichols MD, Jensen J. Comparison of pain and time of procedures with two first-trimester abortion techniques performed by residents and faculty. Am J Obstet Gynecol. 2001 Jun;184(7):1564-7.</citation>
    <PMID>11408881</PMID>
  </reference>
  <reference>
    <citation>Edelman A, Nichols MD, Leclair C, Astley S, Shy K, Jensen JT. Intrauterine lidocaine infusion for pain management in first-trimester abortions. Obstet Gynecol. 2004 Jun;103(6):1267-72.</citation>
    <PMID>15172863</PMID>
  </reference>
  <reference>
    <citation>Edelman A, Nichols MD, Leclair C, Jensen JT. Four percent intrauterine lidocaine infusion for pain management in first-trimester abortions. Obstet Gynecol. 2006 Feb;107(2 Pt 1):269-75.</citation>
    <PMID>16449111</PMID>
  </reference>
  <reference>
    <citation>Heath PJ, Ogg TW. Prophylactic analgesia for daycase termination of pregnancy. A double-blind study with controlled release dihydrocodeine. Anaesthesia. 1989 Dec;44(12):991-4.</citation>
    <PMID>2619027</PMID>
  </reference>
  <reference>
    <citation>Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003 Sep;4(7):407-14.</citation>
    <PMID>14622683</PMID>
  </reference>
  <reference>
    <citation>Kan AS, Ng EH, Ho PC. The role and comparison of two techniques of paracervical block for pain relief during suction evacuation for first-trimester pregnancy termination. Contraception. 2004 Aug;70(2):159-63.</citation>
    <PMID>15288222</PMID>
  </reference>
  <reference>
    <citation>Nichols, M. D., Halvorson-Boyd, G., Goldstein, R., Gevirtz, C., &amp; Healow, D. (2009). Pain management. In M. Paul, E. S. Lichtenberg, L. Borgatta, D. A. Grimes &amp; P. G. Stubblefield (Eds.), Management of unintended and abnormal pregnancy. (pp. 90-110): Wiley-Blackwell.</citation>
  </reference>
  <reference>
    <citation>O'Connell K, Jones HE, Simon M, Saporta V, Paul M, Lichtenberg ES; National Abortion Federation Members. First-trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2009 May;79(5):385-92. doi: 10.1016/j.contraception.2008.11.005. Epub 2008 Dec 11.</citation>
    <PMID>19341852</PMID>
  </reference>
  <reference>
    <citation>Renner RM, Jensen JT, Nichols MD, Edelman A. Pain control in first trimester surgical abortion. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006712. doi: 10.1002/14651858.CD006712.pub2. Review.</citation>
    <PMID>19370649</PMID>
  </reference>
  <reference>
    <citation>Romero I, Turok D, Gilliam M. A randomized trial of tramadol versus ibuprofen as an adjunct to pain control during vacuum aspiration abortion. Contraception. 2008 Jan;77(1):56-9. Epub 2007 Nov 26.</citation>
    <PMID>18082668</PMID>
  </reference>
  <reference>
    <citation>Rowbotham MC. What is a &quot;clinically meaningful&quot; reduction in pain? Pain. 2001 Nov;94(2):131-2. Review.</citation>
    <PMID>11690725</PMID>
  </reference>
  <reference>
    <citation>Singh RH, Ghanem KG, Burke AE, Nichols MD, Rogers K, Blumenthal PD. Predictors and perception of pain in women undergoing first trimester surgical abortion. Contraception. 2008 Aug;78(2):155-61. doi: 10.1016/j.contraception.2008.03.011. Epub 2008 May 27.</citation>
    <PMID>18672118</PMID>
  </reference>
  <reference>
    <citation>Suprapto K, Reed S. Naproxen sodium for pain relief in first-trimester abortion. Am J Obstet Gynecol. 1984 Dec 15;150(8):1000-1.</citation>
    <PMID>6507524</PMID>
  </reference>
  <reference>
    <citation>Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996 Apr;27(4):485-9.</citation>
    <PMID>8604867</PMID>
  </reference>
  <reference>
    <citation>Uppington, J. (2006). Opioids. In J. Ballantyne (Ed.), Massachusetts General Hospital Handbook of Pain Management (pp. 106-126). Philadelphia: Lippincott Williams &amp; Wilkins.</citation>
  </reference>
  <reference>
    <citation>WHO (2003). Safe abortion:Technical and policy guidance for health systems</citation>
  </reference>
  <reference>
    <citation>Wiebe E, Podhradsky L, Dijak V. The effect of lorazepam on pain and anxiety in abortion. Contraception. 2003 Mar;67(3):219-21.</citation>
    <PMID>12618257</PMID>
  </reference>
  <reference>
    <citation>Wiebe ER, Rawling M. Pain control in abortion. Int J Gynaecol Obstet. 1995 Jul;50(1):41-6.</citation>
    <PMID>7556858</PMID>
  </reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2011</study_first_submitted>
  <study_first_submitted_qc>April 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2011</study_first_posted>
  <last_update_submitted>March 20, 2012</last_update_submitted>
  <last_update_submitted_qc>March 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Elizabeth Micks</investigator_full_name>
    <investigator_title>Fellow in Family Planning</investigator_title>
  </responsible_party>
  <keyword>Pain during first trimester surgical abortion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

